ProCare Rx Announces New Executive Appointment and Launch of Technology Division

ProCare Rx • May 20, 2025

ProCare Rx Announces New Executive Appointment and Launch of Technology Division to Drive Innovation and Growth

The newly created role is expected to solidify leadership of the core technology
infrastructure to both enhance support for current clients as well as developing
additional value-added offerings to the marketplace.

Gainesville, GA, - May 19, 2025 - ProCare Rx, a trusted leader in the Pharmacy Benefit Management (PBM) and Claims Processing space, with 38 years of service excellence, is proud to announce that Sathya Srinivasan, an experienced industry visionary, has been named President of its newly established Technology division. This strategic role was created to complement the established PBM business as part of a broader organizational realignment aimed at optimizing the firm’s core technology infrastructure while accelerating the development of innovative, value-added products and services. The move underscores ProCare Rx’s continued commitment to staying at the forefront of technological advancement and delivering exceptional value to its clients.


“We are proud to welcome Sathya to the ProCare Rx leadership team,” said Barbara Rambo, CEO/CFO of ProCare Rx. “He brings deep experience in the Pharmacy Benefits Management (PBM) and Payor Solutions & Services space, with a 20-year, proven track record of building and maintaining long-term, consultative senior executive customer relationships, serving as a trusted business advisor, and delivering thought leadership and innovation. Sathya’s leadership will be instrumental as we continue to fully leverage ProCare Rx’s claims processing and related technology infrastructure to deliver leading edge and technology-based products to serve both internal and external customers.”


Srinivasan was previously at e-Zest Solutions as the Senior Vice President and Healthcare Practice Lead, and prior to that he held various executive roles in operations, delivery, client services, and reporting/analytics with CVS Health, IBM, and GalaxE.Solutions.  His responsibilities included sales, strategy, account management, implementation, client delivery and customer satisfaction. 


“I’m honored to join ProCare Rx at such a transformative time in the PBM industry,” said Sathya Srinivasan, President of ProCare Rx’s Technology business. “With over 20 years of experience in healthcare technology and services, I’m focused on advancing solutions that improve outcomes, drive efficiency, and support brokers, third-party administrators, employers and patients alike. My goal is to lead with purpose and integrity, aligning with ProCare Rx’s mission to deliver innovative, cost-effective solutions that elevate the quality of care and client satisfaction.”



“Sathya’s deep expertise and passion for service, innovation, and operational excellence will be instrumental as we accelerate our growth and expand technology-driven value to clients,” said Ms. Rambo. “His leadership will strengthen the organization’s technical capabilities, drive solution development, and sharpen the competitive edge in the market.”


Sathya is a graduate of the University of Madras – India where he earned a Bachelor of Engineering degree in Computer Science. While he anticipates continuing to leverage his home base in Dallas, TX where he resides with his family, he will dedicate considerable time with the key ProCare Rx team members, clients, and prospects across multiple locations. 


About ProCare Rx
ProCare Rx is a privately held, independent pharmacy benefit manager (PBM) that has empowered healthcare and self-insured organizations since 1988. We provide fully integrated, in-house solutions—including claims adjudication, clinical program design, pharmacy network access, cost containment, and data analytics—all supported in the U.S. Our flexible, transparent model serves self-insured employers, third-party administrators (TPA), brokers, health plans, health systems, managed care organizations (MCO), unions, workers’ compensation programs, Medicare, Medicaid, hospices, and other PBMs. With a proprietary technology platform, commitment to ethical operations, and a focus on lowest net cost, ProCare Rx delivers long-term value, clinical performance, and trusted pharmacy benefit partnerships.

Media Contact:
Marc Cohen, VP, Marketing and Sales
marketing@ProCareRx.com

By ProCare Rx Team August 5, 2025
When Courts and Care Collide: What the Arkansas PBM Ruling Means for the Industry
By ProCare Rx Team July 8, 2025
Prescription Drug Pricing: Will Policy Fix What Patients Feel?
By ProCare Rx Team June 2, 2025
Is Your PBM Working for You…Or Against You? How to Ask the Right Questions and Spot Red Flags in Pharmacy Benefit Management
By ProCare Rx Team May 19, 2025
Understanding the “Most Favored Nation” Drug Pricing Rule
By ProCare Rx Team May 19, 2025
ProCare Rx's Innovative Approach to Pharmacy Benefit Management
By ProCare Rx May 6, 2025
ProCare Rx Appoints John Drakulich as President of their PBM Business
By ProCare Rx Team April 21, 2025
ProCare Rx’s ProCare PharmacyCare, LLC Earns URAC Accreditation in Specialty Pharmacy
By ProCare Rx Team April 15, 2025
Prescription Drug Reform Gains Momentum: What the New Senate Bill Means for Plan Sponsors
By ProCare Rx Team April 2, 2025
The White House recently launched the Make America Healthy Again Commission to address some of the biggest challenges in U.S. healthcare—including chronic disease, medication reliance, and drug safety. While the full impact remains to be seen, this initiative signals potential shifts in how prescription drugs are evaluated, priced, and prescribed. For plan sponsors, employers, and pharmacy benefits managers (PBMs), the key question is: How can we ensure medication access, affordability, and safety while staying ahead of possible regulatory changes? Reevaluating Medication Reliance One of the Commission’s focus areas is over-reliance on medication and treatments. This could lead to a push for more careful prescribing practices, increased scrutiny of high-cost drugs, and expanded support for alternative treatment methods. PBMs can play a proactive role by ensuring plan designs promote clinically effective, cost-conscious prescribing, including: Encouraging use of generics and biosimilars when available Implementing clinical programs that support appropriate prescribing Providing medication management resources to help members navigate treatment options Increased Attention on Drug Safety & Pricing The Commission also highlights food and drug quality and safety , reinforcing the need for greater transparency in pharmaceutical manufacturing and pricing . This could mean: Tighter regulations on imported medications and supply chain oversight More scrutiny on rebate structures and how drug prices are set A renewed focus on affordability strategies for plan sponsors and consumers For PBMs and health plans, transparent pricing models and clear rebate structures will be key to staying compliant and ensuring members have access to safe, fairly priced medications. Eliminating Conflicts of Interest in Health Research Another priority for the Commission is ensuring federally funded health research is free from conflicts of interest . This could impact how drug effectiveness is studied, how formularies are built, and how treatment guidelines are developed. Employers and health plans should work with PBMs that prioritize: Data-driven formulary management based on independent clinical outcomes Objective drug evaluations to balance cost and effectiveness Transparent partnerships with health providers and pharmaceutical companies What’s Next? The Make America Healthy Again Commission is still in its early stages, but its focus on medication reliance, drug safety, and pharmaceutical pricing should not be ignored. Employers and plan sponsors should be prepared for potential policy changes that could impact pharmacy benefits. By working with PBMs that prioritize clinical integrity, cost control, and member education , organizations can stay ahead of the curve and continue to provide high- quality, affordable healthcare solutions. Would you like to review your pharmacy benefits strategy? Let’s talk. Click the button below to learn more about ProCare Rx's Offering and signup to hear from one of our sales team.
By ProCare Rx Team March 3, 2025
FTC Report Reveals $7.3 Billion in Excessive PBM Revenues—What It Means for Employers and Patients